Returning investors included Sanderling Ventures, Mayo Medical Ventures and Walker Ventures. The company plans to use the new funding to continue clinical validation and commercialization of its PEM Flex Solo II PET scanner, which it claims can image tumors less than two millimeters in diameter.
Naviscan, previously based in Rockville, Md., last raised $6.5 million in Nov. 2005. See the company’s release on its latest funding here.
VentureBeatVentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
- up-to-date information on the subjects of interest to you
- our newsletters
- gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
- networking features, and more